Literature DB >> 12681364

Analysis of HLA-G expression in malignant hematopoetic cells from leukemia patients.

Katarína Poláková1, Martina Krcová, Daniel Kuba, Gustáv Russ.   

Abstract

It has been suggested that HLA-G antigens may provide tumor cells with an effective immune escape mechanism. So far mostly solid tumors have been analyzed; HLA-G antigen was only exceptionally detected. To further examine HLA-G expression, patients were chosen with different forms of leukemia: AML (25), CML (4), ALL (9), CLL (8), HCL (2) and NHL (3). Using flow cytometry with three HLA-G specific mAbs (87G, 01G and MEM-G/9), western blotting with two specific mAbs (4H84 and MEM-G/1) and RT-PCR, neither HLA-G antigen nor mRNA for any HLA-G isoform was detected. These results strongly suggest that HLA-G antigen is not expressed in freshly isolated human leukemia cells and therefore is not involved in their escape from immune attack.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12681364     DOI: 10.1016/s0145-2126(02)00228-x

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  7 in total

Review 1.  Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?

Authors:  Laurence Amiot; Soldano Ferrone; Hans Grosse-Wilde; Barbara Seliger
Journal:  Cell Mol Life Sci       Date:  2010-11-10       Impact factor: 9.261

2.  Natural killer cell killing of acute myelogenous leukemia and acute lymphoblastic leukemia blasts by killer cell immunoglobulin-like receptor-negative natural killer cells after NKG2A and LIR-1 blockade.

Authors:  Robert Godal; Veronika Bachanova; Michelle Gleason; Valarie McCullar; Gong H Yun; Sarah Cooley; Michael R Verneris; Philip B McGlave; Jeffrey S Miller
Journal:  Biol Blood Marrow Transplant       Date:  2010-02-06       Impact factor: 5.742

3.  Soluble HLA-G molecules increase during acute leukemia, especially in subtypes affecting monocytic and lymphoid lineages.

Authors:  Frédéric Gros; Yasmine Sebti; Sophie de Guibert; Bernard Branger; Marc Bernard; Renée Fauchet; Laurence Amiot
Journal:  Neoplasia       Date:  2006-03       Impact factor: 5.715

4.  Role of the inhibitory KIR ligand HLA-Bw4 and HLA-C expression levels in the recognition of leukemic cells by Natural Killer cells.

Authors:  Sonja Verheyden; Soldano Ferrone; Arend Mulder; Frans H Claas; Rik Schots; Barbara De Moerloose; Yves Benoit; Christian Demanet
Journal:  Cancer Immunol Immunother       Date:  2008-10-08       Impact factor: 6.968

5.  Determination of HLA-G Expression and Evaluation of Its Role as a Prognostic Factor in Chronic Lymphocytic Leukemia.

Authors:  Gulsum Ozet; Mesude Falay; Simten Dagdas; Funda Ceran
Journal:  J Clin Lab Anal       Date:  2015-08-24       Impact factor: 2.352

6.  Unfavourable clinical implications for HLA-G expression in acute myeloid leukaemia.

Authors:  W-H Yan; A Lin; B-G Chen; W-D Luo; M-Z Dai; X-J Chen; H-H Xu; B-L Li
Journal:  J Cell Mol Med       Date:  2008-06       Impact factor: 5.310

7.  HLA-G expression on blasts and tolerogenic cells in patients affected by acute myeloid leukemia.

Authors:  Grazia Locafaro; Giada Amodio; Daniela Tomasoni; Cristina Tresoldi; Fabio Ciceri; Silvia Gregori
Journal:  J Immunol Res       Date:  2014-03-13       Impact factor: 4.818

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.